T1	Participants 57 108	patients with chronic obstructive pulmonary disease
T2	Participants 171 229	patients with chronic obstructive pulmonary disease (COPD)
T3	Participants 488 506	patients with COPD
T4	Participants 1173 1191	patients with COPD
